TGFB1 and Peritoneal Fibrosis: We treated both ADSC and BM-MSC with TGF-β1, a pleiotropic cytokine released in the peritoneal cavity and the main mediator of peritoneal fibrosis [40, 41], then measured IL-6 in the medium.